Safety, Tolerability, and Efficacy of JBT-101 in Subjects With Dermatomyositis
Clinical trial NCT02466243 · TERMINATED
Trial details
- NCT number
- NCT02466243
- Sponsor
- Corbus Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-08-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.